REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study
Public ClinicalTrials.gov record NCT05611918. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Repeated Assessment of Survivors in ICH (REASSESS ICH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The investigators propose to perform serial detailed cognitive, motor, behavioral, and blood collection follow-up using longitudinal structured telephone interviews of an anticipated 350 ICH survivors enrolled in Minimally Invasive Surgery Plus Alteplase for Intracerebral Hemorrhage Evacuation (MISTIE) III and ENRICH trials to identify specific cognitive and motor impairment and to perform RNA sequencing to evaluate for evidence of chronic inflammation. The investigators' expected sample size in 2022 accounts for mortality attrition of 10%/year.
Study identification
- NCT ID
- NCT05611918
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 350 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 23, 2023 (Actual)
- Primary completion
- Dec 31, 2026 (Estimated)
- Completion
- Dec 31, 2027 (Estimated)
- Last update posted
- Jun 12, 2026
2023 – 2027
United States locations
- U.S. sites
- 26
- U.S. states
- 20
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Brimingham | Birmingham | Alabama | 35294 | — |
| Scripps Health | La Jolla | California | 92037 | — |
| Dignity Health component - St. Joseph's Hospital and Medical Center | Sacramento | California | 95819 | — |
| Stanford University | Stanford | California | 94305 | — |
| Yale University | New Haven | Connecticut | 06511 | — |
| Mayo Clinic, Jacksonville | Jacksonville | Florida | 32224 | — |
| CommonSpirit (formerly Mercy San Juan Medical Center; dignity health) | Chicago | Illinois | 60606 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60607 | — |
| University of Kansas Medical Center | Fairway | Kansas | 66205 | — |
| University of Louisville | Louisville | Kentucky | 40292 | — |
| University of Maryland Baltimore | Baltimore | Maryland | 21201 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21205 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Hennepin Healthcare Research Institute | Minneapolis | Minnesota | 55415 | — |
| Washington University in St. Louis, School of Medicine | St Louis | Missouri | 63130 | — |
| Rutgers - Robert Wood Johnson Medical School | Piscataway | New Jersey | 08854 | — |
| University of New Mexico | Albuquerque | New Mexico | 87131 | — |
| Albert Einstein Montefiore | The Bronx | New York | 10461 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| University of Cincinnati | Cincinnati | Ohio | 45220 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| University of Texas, Houston Health Science Center | Houston | Texas | 77030 | — |
| University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
| Inova Health System Foundation | Fairfax | Virginia | 22042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05611918, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05611918 live on ClinicalTrials.gov.